Steep Hill, the first commercial cannabis testing lab in the US, is expanding into Illinois with a new licensee partner.
Steep Hill CEO Nigel Stobart commented: "We are pleased to partner with Steep Hill Illinois' team. With their success in serial business ventures and commitment to patient and consumer safety with testing, we believe we will see this group expand their horizons quickly."
Co-founder Nick Etten will be driving strategy and business development, as well as government and regulatory issues, co-founder John Tinsley will drive strategy with Nick and focus on business operations, partner relations, launching the Illinois lab, and growth into other markets, and co-founder Matt Grabowski will lead finance and non-laboratory operations.
Steep Hill Illinois will be available to support laboratory and other production activities in 2022. John Tinsley stated, "We are currently building out the lab, which will be strategically placed in Ottawa, Illinois, within a 90-minute drive of the largest MSOs in Illinois." Steep Hill Illinois will provide regulated tests for cannabinoids, pesticides, heavy metals, and more. "We will also provide research and development testing services for cultivators and processors, thus supporting our partners in the development of new products and supporting their growth."